Annual report [Section 13 and 15(d), not S-K Item 405]

INCOME TAXES (Details -Deferred tax assets)

v3.25.2
INCOME TAXES (Details -Deferred tax assets) - USD ($)
Apr. 30, 2025
Apr. 30, 2024
Deferred tax assets:    
Net operating loss carryforwards $ 15,026,112 $ 14,437,888
Stock compensation 523,822 494,130
Research and development 216,831 160,452
Investment in SG Austria 439,953 469,139
Intangible asset (diabetes license) 559,672 596,800
Other - deferred tax asset 147,798 77,622
Total deferred tax assets 16,914,188 16,236,031
Deferred tax liabilities:    
Fair value of derivative liability 0 (174,862)
Fair value of convertible note receivable (568,067) (324,958)
Fair value of warrant asset (228,906) (542,491)
Fair value of investment in TNF (754,512) 0
Other - deferred tax liability (140,985)
Total deferred tax liabilities (1,692,470) (1,042,311)
Total deferred tax assets 15,221,718 15,193,720
Valuation allowance (15,221,718) (15,193,720)
Net deferred tax assets $ 0 $ 0